Masahiro Sugihara
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Radiology, Nuclear Medicine and Imaging top 1%
- Molecular Biology
- Cancer Research top 5%
- Co-authors
- Kaku SaitoShunji TakahashiJunji TsurutaniHiroji IwataToshihiko DoiKenji TamuraHaeseong ParkKohei Shitara
- Topics
- HER2/EGFR in Cancer Research (24 papers)Gastric Cancer Management and Outcomes (13 papers)Monoclonal and Polyclonal Antibodies Research (8 papers)
- Journals
- New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Masahiro Sugihara
47 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Oncology 2.0k
- Pulmonary and Respiratory Medicine 1.2k
- Radiology, Nuclear Medicine and Imaging 905
- Molecular Biology 356
- Cancer Research 355
Countries citing papers authored by Masahiro Sugihara
This map shows the geographic impact of Masahiro Sugihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Sugihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Sugihara more than expected).
Fields of papers citing papers by Masahiro Sugihara
This network shows the impact of papers produced by Masahiro Sugihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Sugihara. The network helps show where Masahiro Sugihara may publish in the future.
Co-authorship network of co-authors of Masahiro Sugihara
This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Sugihara. A scholar is included among the top collaborators of Masahiro Sugihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Sugihara. Masahiro Sugihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 6 | |
| 3 | 2 | |
| 4 | 76 | |
| 5 | 8 | |
| 6 | 2 | |
| 7 | 22 | |
| 8 | 4 | |
| 9 | Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumorsbreakdown → | 248 |
| 10 | Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancerbreakdown → | 802 |
| 11 | Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 studybreakdown → | 258 |
| 12 | 162 | |
| 13 | 52 | |
| 14 | 6 | |
| 15 | 11 | |
| 16 | 27 | |
| 17 | 4 | |
| 18 | 0 | |
| 19 | 0 | |
| 20 | 41 |
About Masahiro Sugihara
Masahiro Sugihara is a scholar working on Microbiology, Oncology and Gastroenterology, having authored 54 papers that have together received 2.6k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (24 papers), Gastric Cancer Management and Outcomes (13 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). The work is most often cited by research in Oncology (2.0k citations), Radiology, Nuclear Medicine and Imaging (905 citations) and Pulmonary and Respiratory Medicine (1.2k citations). Masahiro Sugihara has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Kaku Saito, Shunji Takahashi, Junji Tsurutani, Hiroji Iwata, Toshihiko Doi, Kenji Tamura, Haeseong Park, Kohei Shitara, Kensei Yamaguchi and Ian E. Krop. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.